Aravind Nagarajan

Oncologists on ESMO 2019 and the Potential Impact of Key PARP Inhibitor Data

Following this year’s ESMO annual meeting we asked a group of oncologists practicing in the US to weigh in on Europe’s biggest oncology conference. Oncologists expressed general excitement about the meeting,

Evaluating Print vs. Digital Aids in Oncology

Equipping reps with digital visual aids is a time and cost-intensive exercise. Consequently, sales leadership teams find themselves grappling with the questions:The conventional logic is that digital aids enable sales reps to

We’ve tracked oncology promotional efforts for 120+ brands across 60,000 interactions over the last 5 years.

Oncology sales forces are complex and nuanced. They carry multiple products and indications, often conveying multiple themes in the same interaction, given the breadth of indications a typical oncologist treats. As a result, an oncology interaction is a prioritization exercise...